11 completed, 1 recruiting. 5 Phase 3, 4 Phase 4, 2 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
| Phase 4 | 4 | Completed 4 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow eletriptan: new trials by email Literature Review of eletriptan trials Research Report on eletriptan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord Injury Eletriptan HBr 40 mg - Acute Spinal Cord Injury (SCI) | Phase 1 / Phase 2 | Recruiting | Technophage, SA | 28 | 2025-08-01 | 2025-09-09 |
| BI 44370 TA in Acute Migraine Attack BI 44370 TA Low Dose, Eletriptan, Placebo - Migraine Disorders | Phase 2 | Completed | Boehringer Ingelheim | 416 | 2008-08-01 | 2014-11-24 |
| Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine Zolmitriptan 5 mg Nasal Spray, Eletriptan 40 mg tablet - Acute Migraine, Migraine Headache | Not applicable | Completed | California Medical Clinic for Headache | 80 | 2008-04-01 | 2011-01-14 |
| A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine eletriptan - Migraine | Phase 4 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 220 | 2005-03-01 | 2021-01-27 |
| Prospective Survey of Menstrual Migraine & Prevention With Eletriptan eletriptan - Migraine | Phase 4 | Completed | University of Pittsburgh | 71 | 2004-08-01 | 2011-07-04 |
| Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy Eletriptan - Migraine | Phase 4 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 127 | 2003-01-01 | 2021-01-27 |
| Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory Drugs eletriptan - Migraine | Phase 4 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 120 | 2002-11-01 | 2021-01-27 |
| Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study Placebo, Eletriptan HBr 40 mg, Eletriptan HBr 80 mg - Migraine Without Aura, Migraine With Aura | Phase 3 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 971 | 2000-03-01 | 2021-01-27 |
| Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan Placebo, Eletriptan 40 mg, Eletriptan 80 mg - Migraine With or Without Aura | Phase 3 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 446 | 1999-01-01 | 2021-01-27 |
| Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo Placebo, Eletriptan 40 mg, Eletriptan 80 mg - Migraine With or Without Aura | Phase 3 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1141 | 1996-12-01 | 2021-01-28 |
| Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study Placebo, Eletriptan 40 mg, Eletriptan 80 mg - Migraine With or Without Aura | Phase 3 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1008 | 1996-11-01 | 2021-01-28 |
| Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine Placebo, Eletriptan 20 mg, Eletriptan 40 mg - Migraine With or Without Aura | Phase 3 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1334 | 1996-07-01 | 2021-01-28 |
Migraine Disorders (6) · Headache (1) · Headache Disorders (1) · Migraine with Aura (1) · Migraine without Aura (1)
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (8) · Boehringer Ingelheim (1) · California Medical Clinic for Headache (1) · Technophage, SA (1) · University of Pittsburgh (1)
Netherlands (3) · Spain (3) · Sweden (3) · United States (3) · Belgium (2) · Denmark (2) · France (2) · Germany (2) · Italy (2) · Norway (2) · Turkey (Türkiye) (2) · Canada (1) · Czechia (1) · El Salvador (1) · Finland (1)
David B Kudrow, MD (1) · Dawn Marcus, MD (1)
2023 (1)